Last 12 months
Inside the activity.
1 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2017 Filed Sep 19, 2017 22:15 UTC |
MOLINA J MARIO MDDirector
|
OtherCommon Stock | 83,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053356 · doc4.xml · nonDerivative · entry 13 MOLINA J MARIO MD · CIK 0001246792 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 F4 · kind: On September 15, 2017 the Trustee resigned and was replaced with a corporate trustee. F5 · price: Price not applicable to resignation of trustee. F15 · ownership.nature: The shares are owned by Dr. Molina, as trustee of the Katherine Rose Battiste Trust IV. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 22:15 UTC |
MOLINA J MARIO MDDirector
|
OtherCommon Stock | 28,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053356 · doc4.xml · nonDerivative · entry 11 MOLINA J MARIO MD · CIK 0001246792 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 F4 · kind: On September 15, 2017 the Trustee resigned and was replaced with a corporate trustee. F13 · ownership.nature: The shares are owned by Dr. Molina's spouse, Therese A. Molina, Trustee of the Remainder Trust for Carley F. Fox dated 12/3/2008. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 22:15 UTC |
MOLINA J MARIO MDDirector
|
OtherCommon Stock | 42,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053356 · doc4.xml · nonDerivative · entry 10 MOLINA J MARIO MD · CIK 0001246792 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 F4 · kind: On September 15, 2017 the Trustee resigned and was replaced with a corporate trustee. F5 · price: Price not applicable to resignation of trustee. F12 · ownership.nature: The shares are owned by Dr. Molina's spouse, Therese A. Molina, Trustee of the Remainder Trust for Colleen A.F. Fox dated 12/3/2008. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 22:15 UTC |
MOLINA J MARIO MDDirector
|
OtherCommon Stock | 42,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053356 · doc4.xml · nonDerivative · entry 9 MOLINA J MARIO MD · CIK 0001246792 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 F4 · kind: On September 15, 2017 the Trustee resigned and was replaced with a corporate trustee. F5 · price: Price not applicable to resignation of trustee. F11 · ownership.nature: The shares are owned by Dr. Molina's spouse, Therese A. Molina, Trustee of the Remainder Trust for Mary Clare F. Molina dated 12/3/2008. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 22:15 UTC |
MOLINA J MARIO MDDirector
|
OtherCommon Stock | 42,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053356 · doc4.xml · nonDerivative · entry 8 MOLINA J MARIO MD · CIK 0001246792 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 F4 · kind: On September 15, 2017 the Trustee resigned and was replaced with a corporate trustee. F5 · price: Price not applicable to resignation of trustee. F10 · ownership.nature: The shares are owned by Dr. Molina's spouse, Therese A. Molina, Trustee of the Remainder Trust for David M.F. Molina dated 12/3/2008. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 22:15 UTC |
MOLINA J MARIO MDDirector
|
OtherCommon Stock | 19,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053356 · doc4.xml · nonDerivative · entry 7 MOLINA J MARIO MD · CIK 0001246792 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 F4 · kind: On September 15, 2017 the Trustee resigned and was replaced with a corporate trustee. F5 · price: Price not applicable to resignation of trustee. F9 · ownership.nature: The shares are owned by Dr. Molina, as trustee of the Carley A.F. Fox Trust No. 2 dated 5/14/2003. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 22:15 UTC |
MOLINA J MARIO MDDirector
|
OtherCommon Stock | 18,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053356 · doc4.xml · nonDerivative · entry 6 MOLINA J MARIO MD · CIK 0001246792 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 F4 · kind: On September 15, 2017 the Trustee resigned and was replaced with a corporate trustee. F5 · price: Price not applicable to resignation of trustee. F8 · ownership.nature: The shares are owned by Dr. Molina, as trustee of the Colleen A.F. Fox Trust No. 2 dated 5/14/2003. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 22:15 UTC |
MOLINA J MARIO MDDirector
|
OtherCommon Stock | 18,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053356 · doc4.xml · nonDerivative · entry 5 MOLINA J MARIO MD · CIK 0001246792 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 F4 · kind: On September 15, 2017 the Trustee resigned and was replaced with a corporate trustee. F5 · price: Price not applicable to resignation of trustee. F7 · ownership.nature: The shares are owned by Dr. Molina, as trustee of the Mary Clare F. Molina Trust No. 2 dated 5/14/2003. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 22:15 UTC |
MOLINA J MARIO MDDirector
|
OtherCommon Stock | 18,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053356 · doc4.xml · nonDerivative · entry 4 MOLINA J MARIO MD · CIK 0001246792 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 F4 · kind: On September 15, 2017 the Trustee resigned and was replaced with a corporate trustee. F5 · price: Price not applicable to resignation of trustee. F6 · ownership.nature: The shares are owned by Dr. Molina, as trustee of the David M.F. Molina Trust No. 2 dated 5/14/2003. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 23:03 UTC |
MOLINA JOHN CDirector
|
SaleCommon Stock | 15,208 | $65.79 | $1,000,488.70 |
DisclosureSEC source: 0001209191-17-052711 · doc4.xml · nonDerivative · entry 1 MOLINA JOHN C · CIK 0001246837 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trustee of Family Trust Disclosed balance after: 576,350 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of the John C. Molina Separate Property Trust. F2 · ownership.nature: The shares are owned by the John C. Molina Separate Property Trust, of which Mr. Molina is the trustee and beneficiary. Read SEC document |
| September 08, 2017 Filed Sep 11, 2017 20:28 UTC |
DENTINO WILLIAM10% owner · Trustee of trust owners
PEDERSEN CURTISTrustee of trust owners
MARY R MOLINA LIVING TRUST10% owner
MOLINA MARITAL TRUST10% owner
|
SaleCommon Stock | 2,000 | $65.08 | $130,150.00 |
DisclosureSEC source: 0001209191-17-052229 · doc4.xml · nonDerivative · entry 1 DENTINO WILLIAM · CIK 0001246931 · 10% owner · Trustee of trust owners PEDERSEN CURTIS · CIK 0001246924 · Trustee of trust owners MARY R MOLINA LIVING TRUST · CIK 0001246952 · 10% owner MOLINA MARITAL TRUST · CIK 0001246946 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Trustee Disclosed balance after: 3,517,550 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of the Mary R Molina Living Trust. F2 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was $64.93 to $65.29. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. F3 · ownership.nature: The shares are owned by the Mary R. Molina Living Trust, of which Mr. Dentino and Mr. Pedersen are co-trustees. Read SEC document |
| September 07, 2017 Filed Sep 7, 2017 21:58 UTC |
DENTINO WILLIAM10% owner · Trustee of trust owners
PEDERSEN CURTISTrustee of trust owners
MARY R MOLINA LIVING TRUST10% owner
MOLINA MARITAL TRUST10% owner
|
SaleCommon Stock | 22,000 | $65.02 | $1,430,360.80 |
DisclosureSEC source: 0001209191-17-051945 · doc4.xml · nonDerivative · entry 3 DENTINO WILLIAM · CIK 0001246931 · 10% owner · Trustee of trust owners PEDERSEN CURTIS · CIK 0001246924 · Trustee of trust owners MARY R MOLINA LIVING TRUST · CIK 0001246952 · 10% owner MOLINA MARITAL TRUST · CIK 0001246946 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Trustee Disclosed balance after: 3,519,550 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of the Mary R Molina Living Trust. F5 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was $64.40 to $65.47. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. F3 · ownership.nature: The shares are owned by the Mary R. Molina Living Trust, of which Mr. Dentino and Mr. Pedersen are co-trustees. Read SEC document |
| September 06, 2017 Filed Sep 7, 2017 21:58 UTC |
DENTINO WILLIAM10% owner · Trustee of trust owners
PEDERSEN CURTISTrustee of trust owners
MARY R MOLINA LIVING TRUST10% owner
MOLINA MARITAL TRUST10% owner
|
SaleCommon Stock | 22,000 | $64.63 | $1,421,767.60 |
DisclosureSEC source: 0001209191-17-051945 · doc4.xml · nonDerivative · entry 2 DENTINO WILLIAM · CIK 0001246931 · 10% owner · Trustee of trust owners PEDERSEN CURTIS · CIK 0001246924 · Trustee of trust owners MARY R MOLINA LIVING TRUST · CIK 0001246952 · 10% owner MOLINA MARITAL TRUST · CIK 0001246946 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Trustee Disclosed balance after: 3,541,550 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of the Mary R Molina Living Trust. F4 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transaction was $64.12 to $65.78. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. F3 · ownership.nature: The shares are owned by the Mary R. Molina Living Trust, of which Mr. Dentino and Mr. Pedersen are co-trustees. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 21:58 UTC |
DENTINO WILLIAM10% owner · Trustee of trust owners
PEDERSEN CURTISTrustee of trust owners
MARY R MOLINA LIVING TRUST10% owner
MOLINA MARITAL TRUST10% owner
|
SaleCommon Stock | 22,000 | $64.97 | $1,429,401.60 |
DisclosureSEC source: 0001209191-17-051945 · doc4.xml · nonDerivative · entry 1 DENTINO WILLIAM · CIK 0001246931 · 10% owner · Trustee of trust owners PEDERSEN CURTIS · CIK 0001246924 · Trustee of trust owners MARY R MOLINA LIVING TRUST · CIK 0001246952 · 10% owner MOLINA MARITAL TRUST · CIK 0001246946 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Trustee Disclosed balance after: 3,563,550 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of the Mary R Molina Living Trust. F2 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was $63.79 to $65.44. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. F3 · ownership.nature: The shares are owned by the Mary R. Molina Living Trust, of which Mr. Dentino and Mr. Pedersen are co-trustees. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 21:59 UTC |
MOLINA J MARIO MDDirector
|
SaleCommon Stock | 15,000 | $64.75 | $971,190.00 |
DisclosureSEC source: 0001209191-17-051948 · doc4.xml · nonDerivative · entry 1 MOLINA J MARIO MD · CIK 0001246792 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 143,565 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of Dr. Molina. F2 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was $63.925 to $65.08. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. F3 · ownership.nature: The shares are held by the M/T Molina Family Trust, of which Dr. Molina and his spouse are trustees and beneficiaries. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 23:19 UTC |
ROMNEY RONNADirector
|
SaleCommon Stock | 250 | $63.83 | $15,957.50 |
DisclosureSEC source: 0001179929-17-000184 · wf-form4_150430798303861.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 22,356 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on March 15, 2017. F2 · price: Represents the actual selling price for all 250 shares. F3 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| August 21, 2017 Filed Aug 21, 2017 22:45 UTC |
Rubino Lisa ASenior Vice President
|
SaleCommon Stock | 5,378 | $60.30 | $324,293.40 |
DisclosureSEC source: 0001179929-17-000180 · wf-form4_150335553604821.xml · nonDerivative · entry 1 Rubino Lisa A · CIK 0001681824 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,175 F1 · price: Represents the actual selling price for all 5,378 shares. F2 · balance_after: The shares shall vest as follows: 11,726 on March 1, 2018; 7,745 on March 1, 2019; 5,389 on March 1, 2020; and 3,036 on March 1, 2021. The remainder of the shares are vested. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 23:03 UTC |
MOLINA JOHN CDirector
|
SaleCommon Stock | 25,295 | $59.33 | $1,500,858.59 |
DisclosureSEC source: 0001209191-17-049866 · doc4.xml · nonDerivative · entry 1 MOLINA JOHN C · CIK 0001246837 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 585,859 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of Mr. Molina. F2 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was 58.90 to $59.87. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. Read SEC document |
| August 17, 2017 Filed Aug 17, 2017 22:37 UTC |
ORLANDO STEVEN JDirector
|
SaleCommon Stock | 1,000 | $60.00 | $60,000.00 |
DisclosureSEC source: 0001179929-17-000178 · wf-form4_150300941018928.xml · nonDerivative · entry 1 ORLANDO STEVEN J · CIK 0001211493 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 26,336 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on November 10, 2016. F2 · price: Represents the actual selling price for all 1,000 shares. F3 · ownership.nature: Shares are held by Orlando Family Trust. Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 22:41 UTC |
ORLANDO STEVEN JDirector
|
SaleCommon Stock | 1,500 | $58.00 | $87,000.00 |
DisclosureSEC source: 0001179929-17-000176 · wf-form4_150249128066678.xml · nonDerivative · entry 1 ORLANDO STEVEN J · CIK 0001211493 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 27,336 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on May 16, 2017. F2 · price: Represents the actual selling price for all 1,500 shares. F3 · ownership.nature: Shares are held by Orlando Family Trust. Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 22:41 UTC |
ROMNEY RONNADirector
|
SaleCommon Stock | 250 | $58.00 | $14,500.00 |
DisclosureSEC source: 0001179929-17-000175 · wf-form4_150249126330105.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 22,606 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on March 15, 2017. F2 · price: Represents the actual selling price for all 250 shares. F3 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| August 07, 2017 Filed Aug 7, 2017 21:21 UTC |
DENTINO WILLIAM10% owner · Trustee of trust owners
PEDERSEN CURTISTrustee of trust owners
MARY R MOLINA LIVING TRUST10% owner
MOLINA MARITAL TRUST10% owner
|
SaleCommon Stock | 22,000 | $58.48 | $1,286,513.80 |
DisclosureSEC source: 0001209191-17-047928 · doc4.xml · nonDerivative · entry 3 DENTINO WILLIAM · CIK 0001246931 · 10% owner · Trustee of trust owners PEDERSEN CURTIS · CIK 0001246924 · Trustee of trust owners MARY R MOLINA LIVING TRUST · CIK 0001246952 · 10% owner MOLINA MARITAL TRUST · CIK 0001246946 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Trustee Disclosed balance after: 3,585,550 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of the Mary R Molina Living Trust. F5 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was $58.00 to $58.85. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. F3 · ownership.nature: The shares are owned by the Mary R. Molina Living Trust, of which Mr. Dentino and Mr. Pedersen are co-trustees. Read SEC document |
| August 04, 2017 Filed Aug 7, 2017 21:21 UTC |
DENTINO WILLIAM10% owner · Trustee of trust owners
PEDERSEN CURTISTrustee of trust owners
MARY R MOLINA LIVING TRUST10% owner
MOLINA MARITAL TRUST10% owner
|
SaleCommon Stock | 22,000 | $60.42 | $1,329,262.00 |
DisclosureSEC source: 0001209191-17-047928 · doc4.xml · nonDerivative · entry 2 DENTINO WILLIAM · CIK 0001246931 · 10% owner · Trustee of trust owners PEDERSEN CURTIS · CIK 0001246924 · Trustee of trust owners MARY R MOLINA LIVING TRUST · CIK 0001246952 · 10% owner MOLINA MARITAL TRUST · CIK 0001246946 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Trustee Disclosed balance after: 3,607,550 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of the Mary R Molina Living Trust. F4 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transaction was $58.89 to $62.69. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. F3 · ownership.nature: The shares are owned by the Mary R. Molina Living Trust, of which Mr. Dentino and Mr. Pedersen are co-trustees. Read SEC document |
| August 03, 2017 Filed Aug 7, 2017 21:21 UTC |
DENTINO WILLIAM10% owner · Trustee of trust owners
PEDERSEN CURTISTrustee of trust owners
MARY R MOLINA LIVING TRUST10% owner
MOLINA MARITAL TRUST10% owner
|
SaleCommon Stock | 22,000 | $61.38 | $1,350,360.00 |
DisclosureSEC source: 0001209191-17-047928 · doc4.xml · nonDerivative · entry 1 DENTINO WILLIAM · CIK 0001246931 · 10% owner · Trustee of trust owners PEDERSEN CURTIS · CIK 0001246924 · Trustee of trust owners MARY R MOLINA LIVING TRUST · CIK 0001246952 · 10% owner MOLINA MARITAL TRUST · CIK 0001246946 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Trustee Disclosed balance after: 3,629,550 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of the Mary R Molina Living Trust. F2 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was $59.65 to $62.67. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. F3 · ownership.nature: The shares are owned by the Mary R. Molina Living Trust, of which Mr. Dentino and Mr. Pedersen are co-trustees. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 12:07 UTC |
MOLINA J MARIO MDDirector
|
SaleCommon Stock | 15,000 | $66.67 | $999,981.00 |
DisclosureSEC source: 0001209191-17-047610 · doc4.xml · nonDerivative · entry 1 MOLINA J MARIO MD · CIK 0001246792 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 158,565 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of Dr. Molina. F2 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was $66.32 to $67.64. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. F3 · ownership.nature: The shares are held by the M/T Molina Family Trust, of which Dr. Molina and his spouse are trustees and beneficiaries. Read SEC document |
| July 18, 2017 Filed Jul 19, 2017 23:51 UTC |
MOLINA JOHN CDirector
|
SaleCommon Stock | 21,277 | $70.53 | $1,500,751.92 |
DisclosureSEC source: 0001209191-17-045763 · doc4.xml · nonDerivative · entry 1 MOLINA JOHN C · CIK 0001246837 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 611,154 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of Mr. Molina. F2 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was $70.20 to $70.76. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. Read SEC document |
| July 06, 2017 Filed Jul 6, 2017 22:52 UTC |
DENTINO WILLIAM10% owner · Trustee of trust owners
PEDERSEN CURTISTrustee of trust owners
MARY R MOLINA LIVING TRUST10% owner
MOLINA MARITAL TRUST10% owner
|
SaleCommon Stock | 22,000 | $68.72 | $1,511,736.60 |
DisclosureSEC source: 0001209191-17-044214 · doc4.xml · nonDerivative · entry 3 DENTINO WILLIAM · CIK 0001246931 · 10% owner · Trustee of trust owners PEDERSEN CURTIS · CIK 0001246924 · Trustee of trust owners MARY R MOLINA LIVING TRUST · CIK 0001246952 · 10% owner MOLINA MARITAL TRUST · CIK 0001246946 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Trustee Disclosed balance after: 3,651,550 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of the Mary R Molina Living Trust. F5 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was $67.92 to $69.17. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. F3 · ownership.nature: The shares are owned by the Mary R. Molina Living Trust, of which Mr. Dentino and Mr. Pedersen are co-trustees. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 22:52 UTC |
DENTINO WILLIAM10% owner · Trustee of trust owners
PEDERSEN CURTISTrustee of trust owners
MARY R MOLINA LIVING TRUST10% owner
MOLINA MARITAL TRUST10% owner
|
SaleCommon Stock | 22,000 | $68.76 | $1,512,610.00 |
DisclosureSEC source: 0001209191-17-044214 · doc4.xml · nonDerivative · entry 2 DENTINO WILLIAM · CIK 0001246931 · 10% owner · Trustee of trust owners PEDERSEN CURTIS · CIK 0001246924 · Trustee of trust owners MARY R MOLINA LIVING TRUST · CIK 0001246952 · 10% owner MOLINA MARITAL TRUST · CIK 0001246946 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Trustee Disclosed balance after: 3,673,550 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of the Mary R Molina Living Trust. F4 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transaction was $67.46 to $68.755. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. F3 · ownership.nature: The shares are owned by the Mary R. Molina Living Trust, of which Mr. Dentino and Mr. Pedersen are co-trustees. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 21:52 UTC |
BAYER TERRYChief Operating Officer
|
SaleCommon Stock | 415 | $69.24 | $28,734.60 |
DisclosureSEC source: 0001179929-17-000162 · wf-form4_149929153673012.xml · nonDerivative · entry 2 BAYER TERRY · CIK 0001305822 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,256.5 F3 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on May 12, 2017. The sale previously reported on June 14, 2017 was also pursuant to the Reporting Person's 10b5-1 Plan established on May 12, 2017, not the 10b5-1 Plan established on March 15, 2017. F4 · price: Represents the actual selling price for all 415 shares. F5 · balance_after: The shares vest as follows: (i) 16,033 shares shall vest in one-third increments over three years, on each of March 1, 2018, March 1, 2019, and March 1, 2020; (ii) 5,154 shares shall vest based on the Company's 2017 after tax profit margin; (iii) 5,154 shares shall vest based on the Company's 2018 after tax profit margin; (iv) 5,154 shares shall vest based upon the Company's 2017 STARS ratings; (v) 7,731 shares shall vest upon the Company's achievement of certain business development targets; (vi) 10,309 shares shall vest in two increments on each of March 7, 2018 and March 7, 2019; continued F6 · balance_after: (vii) 2,865 shares shall vest based on the Company's 2017 annual premium revenue achievement; (viii) 2,865 shares shall vest based on the Company's 2017 net profit margin achievement; (ix) 2,865 shares shall vest based on pre-tax income in fiscal year 2017; (x) 2,865 shares shall vest upon the Company's achieving a three-year Total Stockholder Return (TSR) for the three-year period ending December 31, 2017 as determined by ISS calculations that is greater than the median TSR achieved by the Company's 2015 ISS peer group; and (xi) 2,866 shares shall vest on April 1, 2018; the remainder of the shares are vested. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 12:20 UTC |
MOLINA J MARIO MDDirector
|
SaleCommon Stock | 15,000 | $68.58 | $1,028,635.50 |
DisclosureSEC source: 0001209191-17-042919 · doc4.xml · nonDerivative · entry 1 MOLINA J MARIO MD · CIK 0001246792 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 172,770 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of Dr. Molina. F2 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was $68.10 to $69.44. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. F3 · ownership.nature: The shares are held by the M/T Molina Family Trust, of which Dr. Molina and his spouse are trustees and beneficiaries. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 22:52 UTC |
DENTINO WILLIAM10% owner · Trustee of trust owners
PEDERSEN CURTISTrustee of trust owners
MARY R MOLINA LIVING TRUST10% owner
MOLINA MARITAL TRUST10% owner
|
SaleCommon Stock | 22,000 | $68.57 | $1,508,458.60 |
DisclosureSEC source: 0001209191-17-044214 · doc4.xml · nonDerivative · entry 1 DENTINO WILLIAM · CIK 0001246931 · 10% owner · Trustee of trust owners PEDERSEN CURTIS · CIK 0001246924 · Trustee of trust owners MARY R MOLINA LIVING TRUST · CIK 0001246952 · 10% owner MOLINA MARITAL TRUST · CIK 0001246946 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Trustee Disclosed balance after: 3,695,550 F1 · kind: Sale pursuant to the Rule 10b5-1 Trading Plan of the Mary R Molina Living Trust. F2 · price: Represents the weighted average sale price of all sales on the Transaction Date. The range of prices for the transactions was $68.05 to $69.45. The Reporting Person undertakes to provide full information about the transactions to the Commission upon request. F3 · ownership.nature: The shares are owned by the Mary R. Molina Living Trust, of which Mr. Dentino and Mr. Pedersen are co-trustees. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 22:01 UTC |
MOLINA JOHN CDirector
|
GrantCommon Stock | 795 | $69.18 | $54,998.10 |
DisclosureSEC source: 0001209191-17-043534 · doc4.xml · nonDerivative · entry 1 MOLINA JOHN C · CIK 0001246837 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 632,431 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2017, of $69.18. Thus, the grant this quarter for services as a Director is for 795 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2017. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 21:59 UTC |
MOLINA J MARIO MDDirector
|
GrantCommon Stock | 795 | $69.18 | $54,998.10 |
DisclosureSEC source: 0001209191-17-043516 · doc4.xml · nonDerivative · entry 1 MOLINA J MARIO MD · CIK 0001246792 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 173,565 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2017, of $69.18. Thus, the grant this quarter for services as a Director is for 795 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2017. F4 · ownership.nature: The shares are held by the M/T Molina Family Trust, of which Dr. Molina and his spouse are trustees and beneficiaries. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 21:49 UTC |
COOPERMAN DANIELDirector
|
GrantCommon Stock | 795 | $69.18 | $54,998.10 |
DisclosureSEC source: 0001179929-17-000157 · wf-form4_149929134954781.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,787 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2017, of $69.18. Thus, the grant this quarter for services as a Director is for 795 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2017. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 21:50 UTC |
ROMNEY RONNADirector
|
GrantCommon Stock | 795 | $69.18 | $54,998.10 |
DisclosureSEC source: 0001179929-17-000158 · wf-form4_149929138086285.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 22,856 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2017, of $69.18. Thus, the grant this quarter for services as a Director is for 795 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2017. F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 21:49 UTC |
Carruthers GarreyDirector
|
GrantCommon Stock | 795 | $69.18 | $54,998.10 |
DisclosureSEC source: 0001179929-17-000156 · wf-form4_149929133295958.xml · nonDerivative · entry 1 Carruthers Garrey · CIK 0001289443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,516 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2017, of $69.18. Thus, the grant this quarter for services as a Director is for 795 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2017. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 21:48 UTC |
FEDAK CHARLES ZDirector
|
GrantCommon Stock | 795 | $69.18 | $54,998.10 |
DisclosureSEC source: 0001179929-17-000155 · wf-form4_149929130515502.xml · nonDerivative · entry 1 FEDAK CHARLES Z · CIK 0001246680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,111 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2017, of $69.18. Thus, the grant this quarter for services as a Director is for 795 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2017. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 21:48 UTC |
Murray Frank E MDDirector
|
GrantCommon Stock | 795 | $69.18 | $54,998.10 |
DisclosureSEC source: 0001179929-17-000154 · wf-form4_149929128204038.xml · nonDerivative · entry 1 Murray Frank E MD · CIK 0001293647 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 16,011 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2017, of $69.18. Thus, the grant this quarter for services as a Director is for 795 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2017. F4 · ownership.nature: Shares are held by The F E M & I L M Revocable Living Trust. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 21:47 UTC |
WOLF DALE BDirector
|
GrantCommon Stock | 795 | $69.18 | $54,998.10 |
DisclosureSEC source: 0001179929-17-000153 · wf-form4_149929124804625.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,086 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2017, of $69.18. Thus, the grant this quarter for services as a Director is for 795 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2017. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 21:47 UTC |
ORLANDO STEVEN JDirector
|
GrantCommon Stock | 795 | $69.18 | $54,998.10 |
DisclosureSEC source: 0001179929-17-000152 · wf-form4_149929121503392.xml · nonDerivative · entry 1 ORLANDO STEVEN J · CIK 0001211493 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 28,836 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2017, of $69.18. Thus, the grant this quarter for services as a Director is for 795 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2017. F4 · ownership.nature: Shares are held by Orlando Family Trust. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 21:46 UTC |
Schapiro Richard MDirector
|
GrantCommon Stock | 795 | $69.18 | $54,998.10 |
DisclosureSEC source: 0001179929-17-000151 · wf-form4_149929119472640.xml · nonDerivative · entry 1 Schapiro Richard M · CIK 0001649773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,187 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2017, of $69.18. Thus, the grant this quarter for services as a Director is for 795 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2017. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 21:53 UTC |
Nichols NormanPres, MMS
|
GrantCommon Stock | 460 | $54.26 | $24,959.60 |
DisclosureSEC source: 0001179929-17-000164 · wf-form4_149929160210117.xml · nonDerivative · entry 1 Nichols Norman · CIK 0001511301 · Pres, MMS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,762 F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2011 Employee Stock Purchase Plan. F2 · price: Represents the closing price of Issuer's common stock on December 30, 2016. The purchase price is based on the stock's lower market price as of the two following dates: (1) January 1, 2017, the first day of the ESPP offering period, and (2) June 30, 2017, the last day of the ESPP offering period. F3 · balance_after: The shares shall vest as follows: 8,746 on March 1, 2018; 5,672 on March 1, 2019; 3,847 on March 1, 2020; and 2,024 on March 1, 2021. The remainder of the shares are vested. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 21:53 UTC |
Wilson KeithChief Medical Officer
|
GrantCommon Stock | 298 | $54.26 | $16,169.48 |
DisclosureSEC source: 0001179929-17-000163 · wf-form4_149929156843466.xml · nonDerivative · entry 1 Wilson Keith · CIK 0001616582 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,441 F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2011 Employee Stock Purchase Plan. F2 · price: Represents the closing price of Issuer's common stock on December 30, 2016. The purchase price is based on the stock's lower market price as of the two following dates: (1) January 1, 2017, the first day of the ESPP offering period, and (2) June 30, 2017, the last day of the ESPP offering period. F3 · balance_after: The shares shall vest as follows: 6,469 on March 1, 2018; 4,419 on March 1, 2019; 3,143 on March 1, 2020; and 1,771 on March 1, 2021. The remainder of the shares are vested. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 21:52 UTC |
BAYER TERRYChief Operating Officer
|
GrantCommon Stock | 350 | $54.26 | $18,991.00 |
DisclosureSEC source: 0001179929-17-000162 · wf-form4_149929153673012.xml · nonDerivative · entry 1 BAYER TERRY · CIK 0001305822 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,671.5 F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2011 Employee Stock Purchase Plan. F2 · price: Represents the closing price of Issuer's common stock on December 30, 2016. The purchase price is based on the stock's lower market price as of the two following dates: (1) January 1, 2017, the first day of the ESPP offering period, and (2) June 30, 2017, the last day of the ESPP offering period. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 21:52 UTC |
Barlow Jeff D.Chief Legal Officer
|
GrantCommon Stock | 432 | $54.26 | $23,440.32 |
DisclosureSEC source: 0001179929-17-000161 · wf-form4_149929150301097.xml · nonDerivative · entry 1 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,444 F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2011 Employee Stock Purchase Plan. F2 · price: Represents the closing price of Issuer's common stock on December 30, 2016. The purchase price is based on the stock's lower market price as of the two following dates: (1) January 1, 2017, the first day of the ESPP offering period, and (2) June 30, 2017, the last day of the ESPP offering period. F3 · balance_after: The shares vest as follows: (i) 9,474 shares shall vest in one-third increments over three years, on each of March 1, 2018, March 1, 2019, and March 1, 2020; (ii) 3,132 shares shall vest based on the Company's 2017 after tax profit margin; (iii) 3,132 shares shall vest based on the Company's 2018 after tax profit margin; (iv) 3,132 shares shall vest based upon the Company's 2017 STARS ratings; (v) 4,698 shares shall vest upon the Company's achievement of certain business development targets; (vi) 6,263 shares shall vest in two increments on each of March 7, 2018 and March 7, 2019; continued F4 · balance_after: (vii) 1,885 shares shall vest based on the Company's 2017 annual premium revenue achievement; (viii) 1,885 shares shall vest based on the Company's 2017 net profit margin achievement; (ix) 1,885 shares shall vest based on pre-tax income in fiscal year 2017; (x) 1,885 shares shall vest upon the Company's achieving a three-year Total Stockholder Return (TSR) for the three-year period ending December 31, 2017 as determined by ISS calculations that is greater than the median TSR achieved by the Company's 2015 ISS peer group; and (xi) 1,885 shares shall vest on April 1, 2018; the remainder of the shares are vested. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 21:51 UTC |
WHITE JOSEPH W CPAChief Financial Officer · Interim President and CEO
|
GrantCommon Stock | 102 | $54.26 | $5,534.52 |
DisclosureSEC source: 0001179929-17-000160 · wf-form4_149929146228475.xml · nonDerivative · entry 1 WHITE JOSEPH W CPA · CIK 0001246756 · Chief Financial Officer · Interim President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,805 F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2011 Employee Stock Purchase Plan. F2 · price: Represents the closing price of Issuer's common stock on December 30, 2016. The purchase price is based on the stock's lower market price as of the two following dates: (1) January 1, 2017, the first day of the ESPP offering period, and (2) June 30, 2017, the last day of the ESPP offering period. F3 · balance_after: The shares vest as follows: (i) 15,008 shares shall vest in one-third increments over three years, on each of June 5, 2018, June 5, 2019, and June 5, 2020; (ii) 13,847 shares shall vest in one-third increments over three years, on each of March 1, 2018, March 1, 2019, and March 1, 2020; (iii) 4,317 shares shall vest based on the Company's 2017 after tax profit margin; (iv) 4,317 shares shall vest based on the Company's 2018 after tax profit margin; (v) 4,317 shares shall vest based upon the Company's 2017 STARS ratings; (vi) 6,476 shares shall vest upon the Company's achievement of certain business development targets; (vii) 8,636 shares shall vest one half on each of March 7, 2018 and March 7, 2019; continued F4 · balance_after: (viii) 2,262 shares shall vest based on the Company's 2017 annual premium revenue achievement; (ix) 2,262 shares shall vest based on the Company's 2017 net profit margin achievement; (x) 2,262 shares shall vest based on pre-tax income in fiscal year 2017; (xi) 2,262 shares shall vest upon the Company's achieving a three-year Total Stockholder Return (TSR) for the three-year period ending December 31, 2017 as determined by ISS calculations that is greater than the median TSR achieved by the Company's 2015 ISS peer group; and (xii) 2,262 shares shall vest on April 1, 2018; the remainder of the shares are vested. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 21:50 UTC |
Rubino Lisa ASenior Vice President
|
GrantCommon Stock | 281 | $54.26 | $15,247.06 |
DisclosureSEC source: 0001179929-17-000159 · wf-form4_149929142382601.xml · nonDerivative · entry 1 Rubino Lisa A · CIK 0001681824 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,553 F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2011 Employee Stock Purchase Plan. F2 · price: Represents the closing price of Issuer's common stock on December 30, 2016. The purchase price is based on the stock's lower market price as of the two following dates: (1) January 1, 2017, the first day of the ESPP offering period, and (2) June 30, 2017, the last day of the ESPP offering period. F3 · balance_after: The shares shall vest as follows: 11,726 on March 1, 2018; 7,745 on March 1, 2019; 5,389 on March 1, 2020; and 3,036 on March 1, 2021. Read SEC document |
| June 23, 2017 Filed Jun 26, 2017 22:26 UTC |
ROMNEY RONNADirector
|
SaleCommon Stock | 250 | $71.45 | $17,862.50 |
DisclosureSEC source: 0001179929-17-000134 · wf-form4_149851598893421.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 22,061 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on March 15, 2017. F2 · price: Represents the actual selling price for all 250 shares. F3 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:36 UTC |
BAYER TERRYChief Operating Officer
|
SaleCommon Stock | 15,088 | $70.00 | $1,056,160.00 |
DisclosureSEC source: 0001179929-17-000132 · wf-form4_149765976467425.xml · nonDerivative · entry 1 BAYER TERRY · CIK 0001305822 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,321.5 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on March 15, 2017. F2 · price: Represents the actual selling price for all 15,088 shares. F3 · balance_after: The shares vest as follows: (i) 16,033 shares shall vest in one-third increments over three years, on each of March 1, 2018, March 1, 2019, and March 1, 2020; (ii) 5,154 shares shall vest based on the Company's 2017 after tax profit margin; (iii) 5,154 shares shall vest based on the Company's 2018 after tax profit margin; (iv) 5,154 shares shall vest based upon the Company's 2017 STARS ratings; (v) 7,731 shares shall vest upon the Company's achievement of certain business development targets; (vi) 10,309 shares shall vest in two increments on each of March 7, 2018 and March 7, 2019; continued F4 · balance_after: (vii) 2,865 shares shall vest based on the Company's 2017 annual premium revenue achievement; (viii) 2,865 shares shall vest based on the Company's 2017 net profit margin achievement; (ix) 2,865 shares shall vest based on pre-tax income in fiscal year 2017; (x) 2,865 shares shall vest upon the Company's achieving a three-year Total Stockholder Return (TSR) for the three-year period ending December 31, 2017 as determined by ISS calculations that is greater than the median TSR achieved by the Company's 2015 ISS peer group; and (xi) 2,866 shares shall vest on April 1, 2018; the remainder of the shares are vested. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 01:31 UTC |
BAYER TERRYChief Operating Officer
|
SaleCommon Stock | 283 | $67.47 | $19,094.01 |
DisclosureSEC source: 0001179929-17-000130 · wf-form4_149749027776226.xml · nonDerivative · entry 1 BAYER TERRY · CIK 0001305822 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,409.5 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on March 15, 2017. F2 · price: Represents the actual selling price for all 283 shares. F3 · balance_after: The shares vest as follows: (i) 16,033 shares shall vest in one-third increments over three years, on each of March 1, 2018, March 1, 2019, and March 1, 2020; (ii) 5,154 shares shall vest based on the Company's 2017 after tax profit margin; (iii) 5,154 shares shall vest based on the Company's 2018 after tax profit margin; (iv) 5,154 shares shall vest based upon the Company's 2017 STARS ratings; (v) 7,731 shares shall vest upon the Company's achievement of certain business development targets; (vi) 10,309 shares shall vest in two increments on each of March 7, 2018 and March 7, 2019; continued F4 · balance_after: (vii) 2,865 shares shall vest based on the Company's 2017 annual premium revenue achievement; (viii) 2,865 shares shall vest based on the Company's 2017 net profit margin achievement; (ix) 2,865 shares shall vest based on pre-tax income in fiscal year 2017; (x) 2,865 shares shall vest upon the Company's achieving a three-year Total Stockholder Return (TSR) for the three-year period ending December 31, 2017 as determined by ISS calculations that is greater than the median TSR achieved by the Company's 2015 ISS peer group; and (xi) 2,866 shares shall vest on April 1, 2018; the remainder of the shares are vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.